Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04580940
Other study ID # E7160
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 27, 2021
Est. completion date January 14, 2023

Study information

Verified date November 2023
Source Boston Scientific Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series


Description:

This case series aims to illustrate the clinical utility of percutaneous transhepatic cholangiopancreatoscopy using a thin, disposable, flexible endoscope performed by gastroenterological endoscopists and/or interventional radiologists in procedures including but not limited to: - PTCS for tissue diagnosis in cases of surgically or pathologically-altered anatomy, - PTCS for stone removal after surgically or pathologically-altered anatomy, - Percutaneous rendezvous to aid ERCP after failed endoscopic cannulation, - Percutaneous delivery of palliative intraluminal brachytherapy, - Intra-procedural percutaneous salvage procedures when an initial route of access fails


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 14, 2023
Est. primary completion date December 14, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Scheduled for a percutaneous transhepatic procedure to access the pancreaticobiliary anatomy that will accommodate passage of SpyGlass™ Discover Digital Catheter per local standard of practice 2. Written informed consent from patient or legally authorized representative of the patient Exclusion Criteria: 1. Contraindication for cholangiopancreatoscopy 2. Subjects with unresolved adverse event(s) associated with prior percutaneous pancreaticobiliary ductal access 3. <18 years of age 4. Potentially vulnerable subjects, including, but not limited to pregnant women

Study Design


Intervention

Device:
SpyGlass™ Discover Digital System
Observational, prospective, registry study for the clinical utility of the SpyGlass Discover digital catheter during a PTCS procedure.

Locations

Country Name City State
Belgium Erasme University Hospital Brussels
Canada Toronto General Hospital, University Health Network Toronto Ontario
Germany Evangelisches Krakenhaus Düsseldorf Düsseldorf
Hong Kong Prince of Wales Hospital Shatin NewTerritories
India Asian Institute of Gastroenterology Hyderabad Somajiguda
Italy Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma
United States Virginia Mason Medical Center Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
Boston Scientific Corporation

Countries where clinical trial is conducted

United States,  Belgium,  Canada,  Germany,  Hong Kong,  India,  Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Achieving clinical intent of procedure as indicated Physicians will report achieving clinical success by recording the completed procedures compared to procedures planned by 30 days (+/- 3 days) after index PTCS. 1 month
Secondary Number of Adverse Events Serious adverse events related to the study device, accessory devices used through the working channel of the SpyGlass™ Discover Digital Catheter or the cholangiopancreatoscopy portion of the PTCS procedure(s). 1 month
Secondary Technical success Rate at which SpyGlass™ Discover digital catheter can be advanced to the target lesion or stone(s) and visualize the target During index procedure
Secondary Procedural Time Time elapsed between first insertion to last removal of the SpyGlass™ Discover digital catheter During index procedure
Secondary Number of PTCS procedures Number of PTCS procedures required to achieve clinical success until the end of follow-up 1 month
Secondary Endoscopist rating Endoscopist rating of the following attributes when using SpyGlass™ Discover Digital Catheter compared to marketed reusable scopes Ability to complete the procedure Ability to retroflex Ability to selectively advance into targeted ducts Ability to obtain targeted biopsies Ability to grasp stones Ability to guide lithotripsy Ability to suction Ability to irrigate Ability to advance accessories through scope channel Image quality During index procedure
See also
  Status Clinical Trial Phase
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT02971579 - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Not yet recruiting NCT01900938 - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP N/A
Completed NCT01427725 - Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Not yet recruiting NCT05954221 - Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB N/A
Enrolling by invitation NCT02471170 - Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
Completed NCT04705740 - Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography
Recruiting NCT04259580 - Calgary Registry for Advanced and Therapeutic Endoscopy
Recruiting NCT04291651 - UCSF PANC Cyst Registry
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Completed NCT02916199 - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method N/A
Completed NCT03717298 - Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma Phase 2
Recruiting NCT03334708 - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting NCT05249400 - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training N/A
Recruiting NCT05824403 - PAncreatic Disease Cohort of TOuLouse
Active, not recruiting NCT03269994 - Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Phase 3
Enrolling by invitation NCT04329039 - Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics Phase 2/Phase 3
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Completed NCT02337673 - Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Completed NCT01964430 - Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) Phase 3